|
Summary Information: Minerva Neurosciences Inc Common Stock NASDAQ:NERV |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson's disease.
__The following are links to various summary and news pages for __Minerva Neurosciences Inc Common Stock [ NERV ]. __Note: Some Links might not have information for the company. |
|